1. Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers
   Ammad Ahmad Farooqi et al, 2022, International Journal of Molecular Sciences CrossRef
2. IL-6 accelerates renal fibrosis after acute kidney injury via DNMT1-dependent FOXO3a methylation and activation of Wnt/β-catenin pathway
   Xiaoli Guo et al, 2022, International Immunopharmacology CrossRef
3. A predicted risk score based on the expression of 16 autophagy‑related genes for multiple myeloma survival
   Fang‑Xiao Zhu et al, 2019, Oncology Letters CrossRef
4. Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line
   Magdalena Kusaczuk et al, 2016, Tumor Biology CrossRef
5. Synthesis and antitumor activity in vitro of novel berbamine derivatives
   Shui-Gao Wu et al, 2021, Journal of Asian Natural Products Research CrossRef
6. Pharmacological profiling of a berbamine derivative for lymphoma treatment
   Senlin Xu et al, 2024, Blood Advances CrossRef
7. Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis
   Paula Saavedra-García et al, 2018, Molecular and Cellular Endocrinology CrossRef
8. CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ/ Stat3 axis
   Linlin Yang et al, 2020, Aging CrossRef
9. Effect of interleukin-6 on myocardial regeneration in mice after cardiac injury
   Peizhe Tang et al, 2018, Biomedicine & Pharmacotherapy CrossRef